000 01527 a2200457 4500
005 20250518093743.0
264 0 _c20210521
008 202105s 0 0 eng d
022 _a1860-7187
024 7 _a10.1002/cmdc.201900727
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMortier, Jérémie
245 0 0 _aComputationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRAS
_h[electronic resource]
260 _bChemMedChem
_c05 2020
300 _a827-832 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAllosteric Regulation
_xdrug effects
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEnzyme Inhibitors
_xchemistry
650 0 4 _aHumans
650 0 4 _aMolecular Structure
650 0 4 _aMutation
650 0 4 _aProto-Oncogene Proteins p21(ras)
_xantagonists & inhibitors
650 0 4 _aStructure-Activity Relationship
700 1 _aFriberg, Anders
700 1 _aBadock, Volker
700 1 _aMoosmayer, Dieter
700 1 _aSchroeder, Jens
700 1 _aSteigemann, Patrick
700 1 _aSiegel, Franziska
700 1 _aGradl, Stefan
700 1 _aBauser, Marcus
700 1 _aHillig, Roman C
700 1 _aBriem, Hans
700 1 _aEis, Knut
700 1 _aBader, Benjamin
700 1 _aNguyen, Duy
700 1 _aChrist, Clara D
773 0 _tChemMedChem
_gvol. 15
_gno. 10
_gp. 827-832
856 4 0 _uhttps://doi.org/10.1002/cmdc.201900727
_zAvailable from publisher's website
999 _c30804779
_d30804779